Exploring the New FDA-Approved Treatment for Alzheimer's: How Can Leqembi Help My Loved One?
Event Details
RSVP Below
Everything You Need to Know from Our Medical Director Mehrdad Ayati, MD
Kensington Senior Living celebrates the recent FDA approval of Leqembi, a revolutionary new treatment for dementia. This breakthrough not only changes the landscape in the fight against Alzheimer’s, but it also offers a beacon of hope for our residents, their families, and millions of other aging adults living with this disease.
Don’t miss your chance to learn all about this groundbreaking new treatment. We are thrilled to partner with Geriatrician Mehrdad Ayati, MD, our Medical Director, for a complimentary educational event. Whether you are an individual living with dementia, a family caregiver, a healthcare professional, or simply passionate about brain health, this event is for you!
What You Will Learn
Basic Science: How Leqembi Fights Amyloid Plaques in the Brain
Efficacy: Clinical Trials Results and FDA Approval Process
Impact: Who is Eligible and Why, Plus Side Effects
Accessibility: Medicare Coverage
And More!
5:30pm – 6pm: Light Bites, Beverages & Mingling
6pm – 7pm: Presentation
Submit your top questions when you register, and get them answered by Dr. Ayati. Secure your spot now, and let’s come together to explore the potential of Leqembi in the relentless pursuit of a world without Alzheimer’s.
Mehrdad Ayati, MD is Board-Certified in Geriatrics & Family Medicine. He is an Internal Medicine Physician with Stanford Health Care and our Medical Director. He brings a broad spectrum of practice and knowledge of general medicine and primary care in various settings, from office to Emergency room, acute and sub-acute care. Dr. Ayati is a strong advocate for his patients’ physical and mental health in addition to disease management and prevention.
For questions about this event please email Lu Shibli, Community Relations Associate at lshibli@kensintonsl.com.
